Hims & Hers Rallies on FDA Shift Toward Peptide Review
Regulatory optimism and strategic partnerships boost investor confidence despite ongoing risks Shares of Hims & Hers Health (HIMS) surged for ...
Tag: HIMS
Hims & Hers Stock Soars After Strategic Partnership With Novo Nordisk
Telehealth company pivots toward weight-loss drug market following legal dispute and regulatory scrutiny Shares of Hims & Hers Health (HIMS) ...
Hims & Hers Shares Plunge as FDA Tightens Grip on Compounded GLP-1 Drugs
Regulatory crackdown and Novo Nordisk lawsuit rattle investors and reshape weight-loss drug landscape Shares of Hims & Hers Health (HIMS) ...
Hims & Hers Shares Dip Despite Strong Growth as Revenue Misses Forecast
Telehealth company maintains 2025 outlook, expands beyond GLP-1 offerings amid regulatory and partnership setbacks Hims & Hers Health (HIMS) stock ...
Hims & Hers Health Doubles Revenue in Q1 2025, Raises Full-Year Outlook
Surging subscriber growth and profitability prompt ambitious long-term targets for 2030 Hims & Hers Health, Inc. (HIMS), a leading digital ...
Hims & Hers Health Faces Crucial Earnings Test Amid Stock Volatility
Meme-Stock Frenzy Collides with Regulatory Uncertainty and Investor Skepticism Hims & Hers Health (HIMS) is at a crossroads as it ...
